Smith+Nephew’s 2022 results showing revenues up and a commitment to margin expansion and product innovation highlight the company's growth stock potential.
LONDON MARKET OPEN: Stocks lower; UK government surplus beats view lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
The medical products designer revealed attributable profits dived to $223million in 2022, having made $524million the previous year on a recovery in elective surgeries.